Xencor Inc (XNCR)
19.30
-0.81
(-4.03%)
USD |
NASDAQ |
Apr 16, 11:17
Xencor Cash from Investing (Quarterly): -203.13M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -203.13M |
| September 30, 2023 | 45.33M |
| June 30, 2023 | -1.405M |
| March 31, 2023 | 48.14M |
| December 31, 2022 | 24.55M |
| September 30, 2022 | 3.125M |
| June 30, 2022 | -75.64M |
| March 31, 2022 | -71.76M |
| December 31, 2021 | 7.86M |
| September 30, 2021 | -38.85M |
| June 30, 2021 | -53.31M |
| March 31, 2021 | 38.05M |
| December 31, 2020 | 78.78M |
| September 30, 2020 | -50.56M |
| June 30, 2020 | 59.41M |
| March 31, 2020 | 12.56M |
| December 31, 2019 | 15.73M |
| September 30, 2019 | 22.06M |
| June 30, 2019 | -102.43M |
| March 31, 2019 | 13.67M |
| December 31, 2018 | 6.866M |
| September 30, 2018 | 5.862M |
| Date | Value |
|---|---|
| June 30, 2018 | -190.17M |
| March 31, 2018 | 12.67M |
| December 31, 2017 | 8.939M |
| September 30, 2017 | 4.933M |
| June 30, 2017 | 9.439M |
| March 31, 2017 | 8.553M |
| December 31, 2016 | -104.89M |
| September 30, 2016 | -127.66M |
| June 30, 2016 | 8.623M |
| March 31, 2016 | 9.66M |
| December 31, 2015 | -41.69M |
| September 30, 2015 | 6.933M |
| June 30, 2015 | -101.29M |
| March 31, 2015 | -49.06M |
| December 31, 2014 | -0.587M |
| September 30, 2014 | -0.573M |
| June 30, 2014 | -0.675M |
| March 31, 2014 | -0.448M |
| December 31, 2013 | -0.011M |
| September 30, 2013 | -0.384M |
| June 30, 2013 | -0.335M |
| March 31, 2013 | -0.548M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-203.13M
Minimum
Dec 2023
78.78M
Maximum
Dec 2020
-12.71M
Average
7.86M
Median
Dec 2021
Cash from Investing (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | -26.71M |
| Karyopharm Therapeutics Inc | 26.84M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 9.462M |
| iBio Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 181.21M |
| Cash from Financing (Quarterly) | 22.98M |
| Free Cash Flow | 63.86M |
| Free Cash Flow Per Share (Quarterly) | 2.950 |
| Free Cash Flow to Equity (Quarterly) | 158.53M |
| Free Cash Flow to Firm (Quarterly) | 179.50M |
| Free Cash Flow Yield | 5.49% |